Use of microbial communities for human and animal health
AssigneesUNIVERSllEll GENT, Microbial Resource Management Heal
InventorsSam Possemiers, Massimo Marzorati, Tom Van De Wiele, Ilse Scheirlinck, Pieter Van Den Abeele, Selin Bolca, Davide Gottardi
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to a mixture of bacteria belonging to at least six or seven different and specific bacterial species preferably for use in preventing or treating gastro-intestinal disorders. Preferably, the mixture of bacteria are grown together in a fermenter prior to administering the mixture to a subject in order to prevent or treat the disorder.
Claims9
A method of treating a subject to reduce symptoms associated with a gastro-intestinal disorder, the method comprising:
- administering to the subject a composition consisting of bacteria species Faecalibacterium prausnitzii, Butyricicoccus pullicaecorum, Roseburia inulinivorans, Roseburia hominis, Akkermansia muciniphila, Lactobacillus plantarum, and Anaerostipes caccae, and
- optionally at least one pharmaceutically acceptable excipient so as to both increase butyrate production and increase protective effects towards gut barrier function in the subject and thus reduce symptoms associated with the gastro-intestinal disorder in the subject.
A method of treating a subject to reduce symptoms associated with a gastro-intestinal disorder, the method comprising:
- administering to the subject a composition consisting of bacteria species Faecalibacterium prausnitzii, Butyricicoccus pullicaecorum, Roseburia inulinivorans, Akkermansia muciniphila, Lactobacillus plantarum, and Anaerostipes caccae, and
- optionally at least one pharmaceutically acceptable excipient so as to both increase butyrate production and increase protective effects towards gut barrier function in the subject and thus reduce symptoms associated with the gastro-intestinal disorder in the subject.
A method of treating a subject to reduce symptoms associated with a gastro-intestinal disorder, the method comprising:
- administering to the subject a composition consisting of bacteria species Faecalibacterium prausnitzii, Butyricicoccus pullicaecorum, Roseburia inulinivorans, Roseburia hominis, Akkermansia muciniphila, Lactobacillus plantarum, Anaerostipes caccae, Escherichia coli, Enterococcus faecium, Lactobacillus mucosae, Bifidobacterium adolescentis, Bifidobacterium longum, Bacteroides thetaiotaomicron, and Bacteroides vulgatus;
- and
- optionally at least one pharmaceutically acceptable excipient so as to both increase butyrate production and increase protective effects towards gut barrier function in the subject and thus reduce symptoms associated with the gastro-intestinal disorder in the subject.
A method of treating a subject to reduce symptoms associated with a gastro-intestinal disorder, the method comprising:
- administering to the subject a composition consisting of at least one prebiotic and bacteria species Faecalibacterium prausnitzii, Butyricicoccus pullicaecorum, Roseburia inulinivorans, Roseburia hominis, Akkermansia muciniphila, Lactobacillus plantarum, and Anaerostipes caccae;
- and
- optionally at least one pharmaceutically acceptable excipient so as to both increase butyrate production and increase protective effects towards gut barrier function in the subject and thus reduce symptoms associated with the gastro-intestinal disorder in the subject.
A method of treating a subject to reduce symptoms associated with a gastro-intestinal disorder, the method comprising:
- administering to the subject a composition consisting of bacteria species Faecalibacterium prausnitzii, Butyricicoccus pullicaecorum, Roseburia inulinivorans, Akkermansia muciniphila, Lactobacillus plantarum, and Anaerostipes caccae, Escherichia coli, Enterococcus faecium, Lactobacillus mucosae, Bifidobacterium adolescentis, Bifidobacterium longum, Bacteroides thetaiotaomicron, and Bacteroides vulgatus;
- and
- optionally at least one pharmaceutically acceptable excipient so as to both increase butyrate production and increase protective effects towards gut barrier function in the subject and thus reduce symptoms associated with the gastro-intestinal disorder in the subject.
Dependencies are inferred from the claim text.